{
    "code": "52027270",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027270",
    "time": "2021-11-05 03:31:59",
    "許可證字號": "衛部藥輸字第027270號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/11\/13",
    "發證日期": "106\/11\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202727000",
    "中文品名": "英可欣膜衣錠45毫克",
    "英文品名": "Iclusig 45mg film-coated tablets",
    "適應症": "本藥品Iclusig (ponatinib)是一種酪胺酸激酶抑制劑（tyrosine kinase inhibitors, TKI），適用於： \r\n• 治療無法以其他 TKI 治療的慢性期、加速期或急性期慢性骨髓性白血病（CML）或費城染色體陽性急性淋巴性白血病 (Ph+ALL) 成人患者。 \r\n• 治療T315I 陽性之慢性期、加速期或急性期慢性骨髓性白血病(CML)或T315I 陽性之費城染色體陽性急性淋巴性白血病 (Ph+ALL) 成人患者。",
    "劑型": "116膜衣錠",
    "包裝": "2~1000粒塑膠瓶裝(HDPE)",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分",
    "監視期限": "111\/11\/13",
    "主成分略述": "Ponatinib free base",
    "限制項目": "02輸　入 1D須執行風險管理計畫 5F免除銜接性試驗",
    "申請商名稱": "1403301100  台灣大塚製藥股份有限公司",
    "申請商地址": "台北市中山區復興北路378號11樓",
    "主製造廠": [
        {
            "": "CANADA",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "1403304200  台灣大塚製藥股份有限公司中壢工廠",
            "製造廠廠址": "桃園市中壢區吉林路１５號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "委託包裝廠(貼標)"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013005320",
            "成分名稱": "Ponatinib free base",
            "含量描述": "Ponatinib free base(added as ponatinib HCl)",
            "含量": "45.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Iclusig tablets_Chinese PI_IFC0104-110-09-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027270&Seq=004&Type=9"
        },
        {
            "title": "Iclusig tablet_45mg_Label_final-107-01-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027270&Seq=002&Type=8"
        },
        {
            "title": "Iclusig tablet_45mg_Carton_final-107-01-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027270&Seq=001&Type=8"
        }
    ]
}